Pancreatic cancer (metastatic) - nimotuzumab (1st line) [ID513]

  • Discontinued
  • GID-TAG363

Documents

Documents created during the development process.

Pancreatic cancer (metastatic) - nimotuzumab (1st line): draft scope (pre-referral)

Pancreatic cancer (metastatic) - nimotuzumab (1st line): provisional matrix (pre-referral)